These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27198095)

  • 81. Programme evaluation in health services: the use of experimental designs.
    Overton P; Stinson SM
    J Adv Nurs; 1977 Mar; 2(2):137-46. PubMed ID: 584747
    [No Abstract]   [Full Text] [Related]  

  • 82. Quasi-experimental study designs: making a case for non-experimental designs in the spectrum.
    Richters A; Melis RJF
    J Clin Epidemiol; 2017 Nov; 91():146. PubMed ID: 28802673
    [No Abstract]   [Full Text] [Related]  

  • 83. Honoring Uncontrolled Events: Commentary on Slocum et al.
    Horner RH; Machalicek W
    Perspect Behav Sci; 2022 Sep; 45(3):639-645. PubMed ID: 36249168
    [TBL] [Abstract][Full Text] [Related]  

  • 84. QUASI-EXPERIMENTAL RESEARCH DESIGNS IN NURSING.
    BATTLE AO
    Nurs Outlook; 1964 Oct; 12():30-2. PubMed ID: 14198538
    [No Abstract]   [Full Text] [Related]  

  • 85. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Hoaglin DC
    Biom J; 2018 Nov; 60(6):1083-1084. PubMed ID: 30069902
    [No Abstract]   [Full Text] [Related]  

  • 86. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Hoyer A; Kuss O
    Biom J; 2018 Nov; 60(6):1073-1074. PubMed ID: 30069906
    [No Abstract]   [Full Text] [Related]  

  • 87. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Mavridis D
    Biom J; 2018 Nov; 60(6):1081-1082. PubMed ID: 30069918
    [No Abstract]   [Full Text] [Related]  

  • 88. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Kulinskaya E; Dollinger MB
    Biom J; 2018 Nov; 60(6):1066-1067. PubMed ID: 30069937
    [No Abstract]   [Full Text] [Related]  

  • 89. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Pauly M; Welz T
    Biom J; 2018 Nov; 60(6):1075-1076. PubMed ID: 30069949
    [No Abstract]   [Full Text] [Related]  

  • 90. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Rücker G; Schwarzer G
    Biom J; 2018 Nov; 60(6):1071-1072. PubMed ID: 30069962
    [No Abstract]   [Full Text] [Related]  

  • 91. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Simmonds M
    Biom J; 2018 Nov; 60(6):1062-1063. PubMed ID: 30069975
    [No Abstract]   [Full Text] [Related]  

  • 92. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Bender R; Beckmann L
    Biom J; 2018 Nov; 60(6):1077-1078. PubMed ID: 30088287
    [No Abstract]   [Full Text] [Related]  

  • 93. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Ambrogi F; Rota M
    Biom J; 2018 Nov; 60(6):1079-1080. PubMed ID: 30091155
    [No Abstract]   [Full Text] [Related]  

  • 94. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Holling H
    Biom J; 2018 Nov; 60(6):1091-1093. PubMed ID: 30101441
    [No Abstract]   [Full Text] [Related]  

  • 95. Contribution to the discussion of "When should meta-analysis avoid making hidden normality assumptions?".
    Schmid CH
    Biom J; 2018 Nov; 60(6):1087-1088. PubMed ID: 30101466
    [No Abstract]   [Full Text] [Related]  

  • 96. Commentary: Can a Quasi-experimental Design Be a Better Idea than an Experimental One?
    Labrecque JA; Kaufman JS
    Epidemiology; 2016 Jul; 27(4):500-2. PubMed ID: 27031041
    [No Abstract]   [Full Text] [Related]  

  • 97. Erratum: Regression Discontinuity Designs in Health: A Systematic Review.
    Epidemiology; 2021 Jul; 32(4):e15. PubMed ID: 34042078
    [No Abstract]   [Full Text] [Related]  

  • 98. Roadmap for the development of alternative test methods.
    Brecklinghaus T
    Arch Toxicol; 2020 Oct; 94(10):3597-3598. PubMed ID: 32857209
    [No Abstract]   [Full Text] [Related]  

  • 99. Regional data exchange to improve care for veterans after non-VA hospitalization: a randomized controlled trial.
    Dixon BE; Schwartzkopf AL; Guerrero VM; May J; Koufacos NS; Bean AM; Penrod JD; Schubert CC; Boockvar KS
    BMC Med Inform Decis Mak; 2019 Jul; 19(1):125. PubMed ID: 31272427
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ensuring the Quality of Evidence: Using the Best Design to Answer Health IT Questions.
    Weir CR
    Stud Health Technol Inform; 2016; 222():90-101. PubMed ID: 27198095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.